# 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus

> **NCT03156361** · PHASE2 · COMPLETED · sponsor: **Diasome Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DRUG:** HDV insulin lispro 100 UNIT/mL
- **DRUG:** Insulin Lispro 100 Units/mL

## Key facts

- **NCT ID:** NCT03156361
- **Lead sponsor:** Diasome Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-18
- **Primary completion:** 2018-01-15
- **Final completion:** 2018-03-15
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03156361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03156361, "21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03156361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*